Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by World Scientific Publishing Company, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: suffolkbooks, Center moriches, NY, U.S.A.
Book
Condition: VeryGood. Fast Shipping - Safe and Secure 7 days a week!.
Published by World Scientific Publishing Company, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: suffolkbooks, Center moriches, NY, U.S.A.
Book
Condition: Acceptable. Fast Shipping - Safe and Secure 7 days a week!.
Published by World Scientific, Hackensack, N.J., 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: Research Ink, Takoma Park, MD, U.S.A.
Book
Hardback. Condition: As new. Dust Jacket Condition: jacketcondition. vii + 493 pp. book.
Published by Springer, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: booksXpress, Bayonne, NJ, U.S.A.
Book
Hardcover. Condition: new.
Published by World Scientific Publishing Company, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: Basi6 International, Irving, TX, U.S.A.
Book
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Published by World Scientific Publishing Company, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Book
Condition: New. Brand New Original US Edition.We Ship to PO BOX Address also. EXPEDITED shipping option also available for faster delivery.This item may ship from the US or other locations in India depending on your location and availability.
Published by World Scientific Publishing Company, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: SMASS Sellers, IRVING, TX, U.S.A.
Book
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. This item may ship from the US or our Overseas warehouse depending on your location and stock availability. We Ship to PO BOX Location also.
Published by Springer, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Book
Condition: New.
Published by Springer, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by World Scientific Publishing Company, Incorporated, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: Books Puddle, New York, NY, U.S.A.
Book
Condition: New. pp. vii + 493.
Published by Springer, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by World Scientific Publishing Company, Incorporated, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: Majestic Books, Hounslow, United Kingdom
Book
Condition: New. pp. vii + 493 Illus.
Published by Springer New York, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: Buchpark, Trebbin, Germany
Book
Condition: Sehr gut. Zustand: Sehr gut - Buchschnitt verkürzt - gepflegter, sauberer Zustand - Ausgabejahr 2015 | Seiten: 252 | Sprache: Englisch.
Published by Springer New York Mrz 2015, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book centers on gene therapy and gene transfer approaches to prevent or treat chronic virus infections. The main focus is on the Big Three: human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV). Ample anti-HIV drugs are currently available in the clinic and the development of an effective combination therapy has dramatically improved the lifespan and quality of life of infected individuals. A similar trend can already be recognized for HBV and HCV: the development of multiple (directly acting) antiviral drugs and plans to control or even cure the infection. However, approaches that help prevent infection, or which provide long-lasting treatment (such as a cure) remain important goals. Immunization through gene transfer vehicles encoding immunogenic viral proteins shows promise in preventing infections with complex, highly variable, viruses such as HIV-1 or HCV. Gene therapy applications for virus infections have been discussed since the early 1990's. Whereas a true cure seems difficult to achieve for HIV-1 due to its intrinsic property to deposit its genome into that of the host, such attempts may be within reach for HCV where spontaneous viral clearance occurs in a small percentage of the infected individuals. The prospect of original gene therapy approaches may provide alternative ways to reach the same endpoint by, for example, silencing of CCR5 expression post-transcriptionally. Many alternative antiviral strategies have been developed based on a variety of novel molecular methods: e.g. ribozymes. Some studies have progressed towards pre-clinical animal models and a few antiviral gene therapies have progressed towards clinical trials. This book provides an overview of this rapidly progressing field, while focusing on the interface of gene therapy and immunology/vaccinology. 252 pp. Englisch.
Published by Springer New York Okt 2016, 2016
ISBN 10: 1493948652ISBN 13: 9781493948659
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book centers on gene therapy and gene transfer approaches to prevent or treat chronic virus infections. The main focus is on the Big Three: human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV). Ample anti-HIV drugs are currently available in the clinic and the development of an effective combination therapy has dramatically improved the lifespan and quality of life of infected individuals. A similar trend can already be recognized for HBV and HCV: the development of multiple (directly acting) antiviral drugs and plans to control or even cure the infection. However, approaches that help prevent infection, or which provide long-lasting treatment (such as a cure) remain important goals. Immunization through gene transfer vehicles encoding immunogenic viral proteins shows promise in preventing infections with complex, highly variable, viruses such as HIV-1 or HCV. Gene therapy applications for virus infections have been discussed since the early 1990's. Whereas a true cure seems difficult to achieve for HIV-1 due to its intrinsic property to deposit its genome into that of the host, such attempts may be within reach for HCV where spontaneous viral clearance occurs in a small percentage of the infected individuals. The prospect of original gene therapy approaches may provide alternative ways to reach the same endpoint by, for example, silencing of CCR5 expression post-transcriptionally. Many alternative antiviral strategies have been developed based on a variety of novel molecular methods: e.g. ribozymes. Some studies have progressed towards pre-clinical animal models and a few antiviral gene therapies have progressed towards clinical trials. This book provides an overview of this rapidly progressing field, while focusing on the interface of gene therapy and immunology/vaccinology. 252 pp. Englisch.
Published by World Scientific Pub Co Inc, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: booksXpress, Bayonne, NJ, U.S.A.
Book
Hardcover. Condition: new.
Published by Springer, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Book
Condition: New.
Published by Springer New York, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This book focuses on gene therapy and gene transfer approaches to prevent or treat chronoic virus infections Discusses a collection of molecular antiviral strategies (ribozymes, RNAi, RNAu, aptamers, etcCo-published with the American Societ.
Published by Springer New York, 2016
ISBN 10: 1493948652ISBN 13: 9781493948659
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This book focuses on gene therapy and gene transfer approaches to prevent or treat chronoic virus infections Discusses a collection of molecular antiviral strategies (ribozymes, RNAi, RNAu, aptamers, etcCo-published with the American Societ.
Published by Springer New York, 2016
ISBN 10: 1493948652ISBN 13: 9781493948659
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book centers on gene therapy and gene transfer approaches to prevent or treat chronic virus infections. The main focus is on the Big Three: human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV). Ample anti-HIV drugs are currently available in the clinic and the development of an effective combination therapy has dramatically improved the lifespan and quality of life of infected individuals. A similar trend can already be recognized for HBV and HCV: the development of multiple (directly acting) antiviral drugs and plans to control or even cure the infection. However, approaches that help prevent infection, or which provide long-lasting treatment (such as a cure) remain important goals. Immunization through gene transfer vehicles encoding immunogenic viral proteins shows promise in preventing infections with complex, highly variable, viruses such as HIV-1 or HCV. Gene therapy applications for virus infections have been discussed since the early 1990's. Whereas a true cure seems difficult to achieve for HIV-1 due to its intrinsic property to deposit its genome into that of the host, such attempts may be within reach for HCV where spontaneous viral clearance occurs in a small percentage of the infected individuals. The prospect of original gene therapy approaches may provide alternative ways to reach the same endpoint by, for example, silencing of CCR5 expression post-transcriptionally. Many alternative antiviral strategies have been developed based on a variety of novel molecular methods: e.g. ribozymes. Some studies have progressed towards pre-clinical animal models and a few antiviral gene therapies have progressed towards clinical trials. This book provides an overview of this rapidly progressing field, while focusing on the interface of gene therapy and immunology/vaccinology.
Published by Springer New York, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book centers on gene therapy and gene transfer approaches to prevent or treat chronic virus infections. The main focus is on the Big Three: human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV). Ample anti-HIV drugs are currently available in the clinic and the development of an effective combination therapy has dramatically improved the lifespan and quality of life of infected individuals. A similar trend can already be recognized for HBV and HCV: the development of multiple (directly acting) antiviral drugs and plans to control or even cure the infection. However, approaches that help prevent infection, or which provide long-lasting treatment (such as a cure) remain important goals. Immunization through gene transfer vehicles encoding immunogenic viral proteins shows promise in preventing infections with complex, highly variable, viruses such as HIV-1 or HCV. Gene therapy applications for virus infections have been discussed since the early 1990's. Whereas a true cure seems difficult to achieve for HIV-1 due to its intrinsic property to deposit its genome into that of the host, such attempts may be within reach for HCV where spontaneous viral clearance occurs in a small percentage of the infected individuals. The prospect of original gene therapy approaches may provide alternative ways to reach the same endpoint by, for example, silencing of CCR5 expression post-transcriptionally. Many alternative antiviral strategies have been developed based on a variety of novel molecular methods: e.g. ribozymes. Some studies have progressed towards pre-clinical animal models and a few antiviral gene therapies have progressed towards clinical trials. This book provides an overview of this rapidly progressing field, while focusing on the interface of gene therapy and immunology/vaccinology.
Published by Springer, 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: Revaluation Books, Exeter, United Kingdom
Book
Hardcover. Condition: Brand New. 1st edition. 236 pages. 9.50x6.00x0.75 inches. In Stock.
Published by Springer-Verlag New York Inc., 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Book Print on Demand
Hardback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Published by Springer-Verlag New York Inc., 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Book
Condition: New. Editor(s): Berkhout, Ben; Ertl, Hildegund; Weinberg, Marco. Series: Advances in Experimental Medicine and Biology. Num Pages: 236 pages, 6 black & white illustrations, 35 colour illustrations, 7 black & white tables, biography. BIC Classification: MBGR; MFN; MJCM; MMZ. Category: (P) Professional & Vocational. Dimension: 247 x 163 x 16. Weight in Grams: 502. . 2015. 2015th Edition. Hardcover. . . . .
Published by World Scientific Publishing Company, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Book
Condition: New.
Published by World Scientific Publishing Co Pte Ltd, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Book
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.
Published by Springer-Verlag New York Inc., 2015
ISBN 10: 1493924311ISBN 13: 9781493924318
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Book
Condition: New. Editor(s): Berkhout, Ben; Ertl, Hildegund; Weinberg, Marco. Series: Advances in Experimental Medicine and Biology. Num Pages: 236 pages, 6 black & white illustrations, 35 colour illustrations, 7 black & white tables, biography. BIC Classification: MBGR; MFN; MJCM; MMZ. Category: (P) Professional & Vocational. Dimension: 247 x 163 x 16. Weight in Grams: 502. . 2015. 2015th Edition. Hardcover. . . . . Books ship from the US and Ireland.
Published by World Scientific Publishing Company, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by World Scientific Publishing Company, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Book
Condition: New.
Published by World Scientific Publishing Company, 2010
ISBN 10: 9814295302ISBN 13: 9789814295307
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Book
Condition: As New. Unread book in perfect condition.